Genetics and epigenetics of Parkinson's disease

The Scientific World Journal

Volumn 2012, Issue , 2012, Pages

  Copped, Fabio ^a,b  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; ATAXIN 1; DJ 1 PROTEIN; LEUCINE RICH REPEAT KINASE 2; NEUROPEPTIDE; PARKIN; PHOSPHOTRANSFERASE; PROTEIN ATP13A2; PROTEIN POLG1; PROTEIN SCA2; PTEN INDUCED PUTATIVE KINASE 1; SPATACSIN; TAU PROTEIN; UNCLASSIFIED DRUG; ATP13A2 PROTEIN, HUMAN; LRRK2 PROTEIN, HUMAN; ONCOPROTEIN; PARK7 PROTEIN, HUMAN; PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; PTEN INDUCED PUTATIVE KINASE; PTEN-INDUCED PUTATIVE KINASE; SIGNAL PEPTIDE; UBIQUITIN PROTEIN LIGASE;

AUTOSOMAL DOMINANT DISORDER; DNA METHYLATION; EPIGENETICS; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; HISTONE MODIFICATION; HUMAN; PARKINSON DISEASE; PARKINSONISM; REVIEW; ARTICLE; GENETIC EPIGENESIS; GENETICS; MUTATION;

ALPHA-SYNUCLEIN; EPIGENESIS, GENETIC; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MUTATION; ONCOGENE PROTEINS; PARKINSON DISEASE; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTON-TRANSLOCATING ATPASES; UBIQUITIN-PROTEIN LIGASES;

EID: 84862317109     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2012/489830     Document Type: Review

References (116)

1. Thomas B., Beal M. F., Molecular insights into Parkinson's disease F1000 Medicine Reports 2011 3 7
2. Nuytemans K., Theuns J., Cruts M., Van Broeckhoven C., Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update Human Mutation 2010 31 7 763 780
3. Ramirez A., Heimbach A., Grndemann J., Stiller B., Hampshire D., Cid L. P., Goebel I., Mubaidin A. F., Wriekat A. L., Roeper J., Al-Din A., Hillmer A. M., Karsak M., Liss B., Woods C. G., Behrens M. I., Kubisch C., Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase Nature Genetics 2006 38 10 1184 1191 (Pubitemid 44470365)
4. Migliore L., Copped F., Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases Mutation Research 2009 667 1-2 82 97
5. Polymeropoulos M. H., Lavedan C., Leroy E., Ide S. E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E. S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W. G., Lazzarini A. M., Duvoisin R. C., Di Iorio G., Golbe L. I., Nussbaum R. L., Mutation in the -synuclein gene identified in families with Parkinson's disease Science 1997 276 5321 2045 2047 (Pubitemid 27443610)
6. Krger R., Kuhn W., Mller T., Woitalla D., Graeber M., Ksel S., Przuntek H., Epplen J. T., Schls L., Riess O., Ala30Pro mutation in the gene encoding -synuclein in Parkinson's disease Nature Genetics 1998 18 2 106 108
7. Zarranz J. J., Alegre J., Gmez-Esteban J. C., Lezcano E., Ros R., Ampuero I., Vidal L., Hoenicka J., Rodriguez O., Atarés B., Llorens V., Gomez Tortosa E., Del Ser T., Muoz D. G., De Yebenes J. G., The new mutation, E46K, of -synuclein causes Parkinson and Lewy body dementia Annals of Neurology 2004 55 2 164 173 (Pubitemid 38166992)
8. Singleton A. B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., Hulihan M., Peuralinna T., Dutra A., Nussbaum R., Lincoln S., Crawley A., Hanson M., Maraganore D., Adler C., Cookson M. R., Muenter M., Baptista M., Miller D., Blancato J., Hardy J., Gwinn-Hardy K., -synuclein locus triplication causes Parkinson's disease Science 2003 302 5646 841 (Pubitemid 37339619)
9. Chartier-Harlin M. C., Kachergus J., Roumier C., Mouroux V., Douay X., Lincoln S., Levecque C., Larvor L., Andrieux J., Hulihan M., Waucquier N., Defebvre L., Amouyel P., Farrer M., Destée A., -synuclein locus duplication as a cause of familial Parkinson's disease The Lancet 2004 364 9440 1167 1169 (Pubitemid 39296604)
10. Paisn-Ruz C., Jain S., Evans E. W., Gilks W. P., Simn J., Van Der Brug M., De Munain A. L., Aparicio S., Gil A. M., Khan N., Johnson J., Martinez J. R., Nicholl D., Carrera I. M., Pea A. S., De Silva R., Lees A., Mart-Mass J. F., Pérez-Tur J., Wood N. W., Singleton A. B., Cloning of the gene containing mutations that cause PARK8 -linked Parkinson's disease Neuron 2004 44 4 595 600 (Pubitemid 39531224)
11. Zimprich A., Biskup S., Leitner P., Lichtner P., Farrer M., Lincoln S., Kachergus J., Hulihan M., Uitti R. J., Calne D. B., Stoessl A. J., Pfeiffer R. F., Patenge N., Carbajal I. C., Vieregge P., Asmus F., Mller-Myhsok B., Dickson D. W., Meitinger T., Strom T. M., Wszolek Z. K., Gasser T., Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology Neuron 2004 44 4 601 607 (Pubitemid 39531225)
12. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., Shimizu N., Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism Nature 1998 392 6676 605 608 (Pubitemid 28207717)
13. Valente E. M., Abou-Sleiman P. M., Caputo V., Muqit M. M. K., Harvey K., Gispert S., Ali Z., Del Turco D., Bentivoglio A. R., Healy D. G., Albanese A., Nussbaum R., Gonzlez-Maldonado R., Deller T., Salvi S., Cortelli P., Gilks W. P., Latchman D. S., Harvey R. J., Dallapiccola B., Auburger G., Wood N. W., Hereditary early-onset Parkinson's disease caused by mutations in PINK1 Science 2004 304 5674 1158 1160 (Pubitemid 38661852)
14. Van Duijn C. M., Dekker M. C. J., Bonifati V., Galjaard R. J., Houwing-Duistermaat J. J., Snijders P. J. L. M., Testers L., Breedveld G. J., Horstink M., Sandkuijl L. A., Van Swieten J. C., Oostra B. A., Heutink P., PARK7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36 American Journal of Human Genetics 2001 69 3 629 634 (Pubitemid 32777700)
15. Lockhart P. J., Lincoln S., Hulihan M., Kachergus J., Wilkes K., Bisceglio G., Mash D. C., Farrer M. J., DJ-1 mutations are a rare cause of recessively inherited early onset parkinsonism mediated by loss of protein function Journal of Medical Genetics 2004 41 3 e22
16. Hampshire D. J., Roberts E., Crow Y., Bond J., Mubaidin A., Wriekat A. L., Al-Din A., Woods C. G., Kufor-Rakeb syndrome, pallido-pyramidal degeneration with supranuclear upgaze paresis and dementia, maps to 1p36 Journal of Medical Genetics 2001 38 10 680 682 (Pubitemid 32946789)
17. Liu Y., Fallon L., Lashuel H. A., Liu Z., Lansbury P. T., The UCH-L1 gene encodes two opposing enzymatic activities that affect -synuclein degradation and Parkinson's disease susceptibility Cell 2002 111 2 209 218 (Pubitemid 35292441)
18. Lautier C., Goldwurm S., Drr A., Giovannone B., Tsiaras W. G., Pezzoli G., Brice A., Smith R. J., Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease American Journal of Human Genetics 2008 82 4 822 833
19. Higashi S., Iseki E., Minegishi M., Togo T., Kabuta T., Wada K., GIGYF2 is present in endosomal compartments in the mammalian brains and enhances IGF-1-induced ERK1/2 activation Journal of Neurochemistry 2010 115 2 423 437
20. Strauss K. M., Martins L. M., Plun-Favreau H., Marx F. P., Kautzmann S., Berg D., Gasser T., Wszolek Z., Mller T., Bornemann A., Wolburg H., Downward J., Riess O., Schulz J. B., Krger R., Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease Human Molecular Genetics 2005 14 15 2099 2111 (Pubitemid 41418010)
21. Paisn-Ruiz C., Guevara R., Federoff M., Hanagasi H., Sina F., Elahi E., Schneider S. A., Schwingenschuh P., Bajaj N., Emre M., Singleton A. B., Hardy J., Bhatia K. P., Brandner S., Lees A. J., Houlden H., Early-onset L-dopa-responsive Parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and Spatacsin mutations Movement Disorders 2010 25 12 1791 1800
22. Shojaee S., Sina F., Banihosseini S. S., Kazemi M. H., Kalhor R., Shahidi G. A., Fakhrai-Rad H., Ronaghi M., Elahi E., Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500K SNP arrays American Journal of Human Genetics 2008 82 6 1375 1384
23. Fonzo A. D., Dekker M. C. J., Montagna P., Baruzzi A., Yonova E. H., Guedes L. C., Szczerbinska A., Zhao T., Dubbel-Hulsman L. O. M., Wouters C. H., De Graaff E., Oyen W. J. G., Simons E. J., Breedveld G. J., Oostra B. A., Horstink M. W., Bonifati V., FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome Neurology 2009 72 3 240 245
24. Hardy J., Genetic analysis of pathways to parkinson disease Neuron 2010 68 2 201 206
25. Nalls M. A., Plagnol V., Hernandez D. G., Sharma M., Sheerin U.-M., Saad M., Simn-Snchez J., Schulte C., Lesage S., Sveinbjrnsdttir S., Stefnsson K., Martinez M., Hardy J., Heutink P., Brice A., Gasser T., Singleton A. B., Wood N. W., Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies The Lancet 2011 377 9766 641 649
26. Copped F., One-carbon metabolism and Alzheimer's disease: focus on epigenetics Current Genomics 2010 11 4 246 260
27. Qureshi I. A., Mehler M. F., Advances in epigenetics and epigenomics for neurodegenerative diseases Current Neurology and Neuroscience Reports 2011 11 5 464 473
28. Marques S. C. F., Oliveira C. R., Pereira C. M. F., Outeiro T. F., Epigenetics in neurodegeneration: a new layer of complexity Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011 35 348 355
29. Chen M., Zhang L., Epigenetic mechanisms in developmental programming of adult disease Drug Discovery Today 2011 16 23-24 1007 1018
30. Dumanchin C., Camuzat A., Campion D., Verpillat P., Hannequin D., Dubois B., Saugier-Veber P., Martin C., Penet C., Charbonnier F., Agid Y., Frebourg T., Brice A., Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism Human Molecular Genetics 1998 7 11 1825 1829 (Pubitemid 28464159)
31. Spillantini M. G., Goedert M., Tau mutations in familial frontotemporal dementia Brain 2000 123 5 857 859 (Pubitemid 30224183)
32. Lastres-Becker I., Rb U., Auburger G., Spinocerebellar ataxia 2 (SCA2) Cerebellum 2008 7 2 115 124
33. Matos C. A., de Macedo-Ribeiro S., Carvalho A. L., Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease Progress in Neurobiology 2011 95 1 26 48
34. Lu C. S., Chang H. C., Kuo P. C., Liu Y. L., Wu W. S., Weng Y. H., Yen T. C., Chou Y. H. W., The parkinsonian phenotype of spinocerebellar ataxia type 3 in a Taiwanese family Parkinsonism and Related Disorders 2004 10 6 369 373
35. Kim J. M., Hong S., Gyoung P. K., Yoon J. C., Yu K. K., Sung S. P., Sang E. K., Jeon B. S., Importance of low-range CAG expansion and CAA interruption in SCA2 parkinsonism Archives of Neurology 2007 64 10 1510 1518 (Pubitemid 47572675)
36. Anheim M., Lagier-Tourenne C., Stevanin G., Fleury M., Durr A., Namer I. J., Denora P., Brice A., Mandel J. L., Koenig M., Tranchant C., SPG11 spastic paraplegia: a new cause of juvenile parkinsonism Journal of Neurology 2009 256 1 104 108
37. Guidubaldi A., Piano C., Santorelli F. M., Silvestri G., Petracca M., Tessa A., Bentivoglio A. R., Novel mutations in SPG11 cause hereditary spastic paraplegia associated with early-onset levodopa-responsive Parkinsonism Movement Disorders 2011 26 3 553 556
38. Orsucci D., Caldarazzo Ienco E., Mancuso M., Siciliano G., POLG1-Related and other Mitochondrial Parkinsonisms: an overview Journal of Molecular Neuroscience 2011 44 17 24
39. Abeliovich A., Schmitz Y., Farias I., Choi-Lundberg D., Ho W. H., Castillo P. E., Shinsky N., Garcia Verdugo J. M., Armanini M., Ryan A., Hynes M., Phillips H., Sulzer D., Rosenthal A., Mice lacking -synuclein display functional deficits in the nigrostriatal dopamine system Neuron 2000 25 1 239 252 (Pubitemid 30316525)
40. Liu S., Ninan I., Antonova I., Battaglia F., Trinchese F., Narasanna A., Kolodilov N., Dauer W., Hawkins R. D., Arancio O., -synuclein produces a long-lasting increase in neurotransmitter release EMBO Journal 2004 23 22 4506 4516 (Pubitemid 39601975)
41. Mata I. F., Lockhart P. J., Farrer M. J., Parkin genetics: one model for Parkinson's disease Human Molecular Genetics 2004 13 1 R127 R133
42. Leroy E., Boyer R., Auburger G., Leube B., Ulm G., Mezey E., Harta G., Brownstein M. J., Jonnalagada S., Chernova T., Dehejia A., Lavedan C., Gasser T., Steinbach P. J., Wilkinson K. D., Polymeropoulos M. H., The ubiquitin pathway in Parkinson's disease Nature 1998 395 6701 451 452
43. Narendra D., Tanaka A., Suen D. F., Youle R. J., Parkin is recruited selectively to impaired mitochondria and promotes their autophagy Journal of Cell Biology 2008 183 5 795 803
44. Deng H., Dodson M. W., Huang H., Guo M., The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila Proceedings of the National Academy of Sciences of the United States of America 2008 105 38 14503 14508
45. Poole A. C., Thomas R. E., Andrews L. A., McBride H. M., Whitworth A. J., Pallanck L. J., The PINK1/Parkin pathway regulates mitochondrial morphology Proceedings of the National Academy of Sciences of the United States of America 2008 105 5 1638 1643 (Pubitemid 351346567)
46. Berger A. K., Cortese G. P., Amodeo K. D., Weihofen A., Letai A., LaVoie M. J., Parkin selectively alters the intrinsic threshold for mitochondrial cytochrome c release Human Molecular Genetics 2009 18 22 4317 4328
47. Rothfuss O., Fischer H., Hasegawa T., Maisel M., Leitner P., Miesel F., Sharma M., Bornemann A., Berg D., Gasser T., Patenge N., Parkin protects mitochondrial genome integrity and supports mitochondrial DNA repair Human Molecular Genetics 2009 18 20 3832 3850
48. Kawajiri S., Saiki S., Sato S., Hattori N., Genetic mutations and functions of PINK1 Trends in Pharmacological Sciences 2011 32 10 573 580
49. Xiong H., Wang D., Chen L., Yeun S. C., Ma H., Tang C., Xia K., Jiang W., Ronai Z., Zhuang X., Zhang Z., Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation Journal of Clinical Investigation 2009 119 3 650 660
50. Thomas K. J., McCoy M. K., Blackinton J., Beilina A., van der Brug M., Sandebring A., Miller D., Maric D., Cedazo-Minguez A., Cookson M. R., DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy Human Molecular Genetics 2011 20 1 40 50
51. Tan J., Zhang T., Jiang L., Chi J., Hu D., Pan Q., Wang D., Zhang Z., Regulation of intracellular manganese homeostasis by Kufor-Rakeb syndrome-associated ATP13A2 protein Journal of Biological Chemistry 2011 286 34 29654 29662
52. Lill C. M., Roehr J. T., McQueen M. B., The PDGene Database. Alzheimer Research Forum, http://www.pdgene.org/
53. Maraganore D. M., De Andrade M., Elbaz A., Farrer M. J., Ioannidis J. P., Krger R., Rocca W. A., Schneider N. K., Lesnick T. G., Lincoln S. J., Hulihan M. M., Aasly J. O., Ashizawa T., Chartier-Harlin M.-C., Checkoway H., Ferrarese C., Hadjigeorgiou G., Hattori N., Kawakami H., Lambert J.-C., Lynch T., Mellick G. D., Papapetropoulos S., Collaborative analysis of -synuclein gene promoter variability and Parkinson disease Journal of the American Medical Association 2006 296 6 661 670 (Pubitemid 44200637)
54. Mata I. F., Yearout D., Alvarez V., Coto E., de Mena L., Ribacoba R., Lorenzo-Betancor O., Samaranch L., Pastor P., Cervantes S., Infante J., Garcia-Gorostiaga I., Sierra M., Combarros O., Snapinn K. W., Edwards K. L., Zabetian C. P., Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson's disease Movement Disorders 2011 26 5 819 823
55. Pankratz N., Wilk J. B., Latourelle J. C., DeStefano A. L., Halter C., Pugh E. W., Doheny K. F., Gusella J. F., Nichols W. C., Foroud T., Myers R. H., Genomewide association study for susceptibility genes contributing to familial Parkinson disease Human Genetics 2009 124 6 593 605
56. Simn-Snchez J., Schulte C., Bras J. M., Sharma M., Gibbs J. R., Berg D., Paisan-Ruiz C., Lichtner P., Scholz S. W., Hernandez D. G., Krger R., Federoff M., Klein C., Goate A., Perlmutter J., Bonin M., Nalls M. A., Illig T., Gieger C., Houlden H., Steffens M., Okun M. S., Racette B. A., Cookson M. R., Foote K. D., Fernandez H. H., Traynor B. J., Schreiber S., Arepalli S., Zonozi R., Gwinn K., Van Der Brug M., Lopez G., Chanock S. J., Schatzkin A., Park Y., Hollenbeck A., Gao J., Huang X., Wood N. W., Lorenz D., Deuschl G., Chen H., Riess O., Hardy J. A., Singleton A. B., Gasser T., Genome-wide association study reveals genetic risk underlying Parkinson's disease Nature Genetics 2009 41 12 1308 1312
57. Edwards T. L., Scott W. K., Almonte C., Burt A., Powell E. H., Beecham G. W., Wang L., Zchner S., Konidari I., Wang G., Singer C., Nahab F., Scott B., Stajich J. M., Pericak-Vance M., Haines J., Vance J. M., Martin E. R., Genome-Wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for parkinson disease Annals of Human Genetics 2010 74 2 97 109
58. Satake W., Nakabayashi Y., Mizuta I., Hirota Y., Ito C., Kubo M., Kawaguchi T., Tsunoda T., Watanabe M., Takeda A., Tomiyama H., Nakashima K., Hasegawa K., Obata F., Yoshikawa T., Kawakami H., Sakoda S., Yamamoto M., Hattori N., Murata M., Nakamura Y., Toda T., Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease Nature Genetics 2009 41 12 1303 1307
59. Fuchs J., Tichopad A., Golub Y., Munz M., Schweitzer K. J., Wolf B., Berg D., Mueller J. C., Gasser T., Genetic variability in the SNCA gene influences -synuclein levels in the blood and brain FASEB Journal 2008 22 5 1327 1334 (Pubitemid 351656774)
60. Goris A., Williams-Gray C. H., Clark G. R., Foltynie T., Lewis S. J. G., Brown J., Ban M., Spillantini M. G., Compston A., Burn D. J., Chinnery P. F., Barker R. A., Sawcer S. J., Tau and -synuclein in susceptibility to, and dementia in, Parkinson's disease Annals of Neurology 2007 62 2 145 153 (Pubitemid 47546500)
61. Farrer M. J., Stone J. T., Lin C. H., Dchsel J. C., Hulihan M. M., Haugarvoll K., Ross O. A., Wu R. M., Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia Parkinsonism and Related Disorders 2007 13 2 89 92 (Pubitemid 46329522)
62. Zabetian C. P., Hutter C. M., Factor S. A., Nutt J. G., Higgins D. S., Griffith A., Roberts J. W., Leis B. C., Kay D. M., Yearout D., Montimurro J. S., Edwards K. L., Samii A., Payami H., Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease Annals of Neurology 2007 62 2 137 144 (Pubitemid 47546499)
63. Velayati A., Yu W. H., Sidransky E., The role of glucocerebrosidase mutations in parkinson disease and lewy body disorders Current Neurology and Neuroscience Reports 2010 10 3 190 198
64. Tayebi N., Walker J., Stubblefield B., Orvisky E., LaMarca M. E., Wong K., Rosenbaum H., Schiffmann R., Bembi B., Sidransky E., Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Molecular Genetics and Metabolism 2003 79 2 104 109 (Pubitemid 36693928)
65. Halperin A., Elstein D., Zimran A., Increased incidence of Parkinson disease among relatives of patients with Gaucher disease Blood Cells, Molecules, and Diseases 2006 36 3 426 428 (Pubitemid 43776190)
66. Sidransky E., Nalls M. A., Aasly J. O., Aharon-Peretz J., Annesi G., Barbosa E. R., Bar-Shira A., Berg D., Bras J., Brice A., Chen C. M., Clark L. N., Condroyer C., De Marco E. V., Drr A., Eblan M. J., Fahn S., Farrer M. J., Fung H. C., Gan-Or Z., Gasser T., Gershoni-Baruch R., Giladi N., Griffith A., Gurevich T., Januario C., Kropp P., Lang A. E., Lee-Chen G. J., Lesage S., Marder K., Mata I. F., Mirelman A., Mitsui J., Mizuta I., Nicoletti G., Oliveira C., Ottman R., Orr-Urtreger A., Pereira L. V., Quattrone A., Rogaeva E., Rolfs A., Rosenbaum H., Rozenberg R., Samii A., Samaddar T., Schulte C., Sharma M., Singleton A., Spitz M., Tan E. K., Tayebi N., Toda T., Troiano A. R., Tsuji S., Wittstock M., Wolfsberg T. G., Wu Y. R., Zabetian C. P., Zhao Y., Ziegler S. G., Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease New England Journal of Medicine 2009 361 17 1651 1661
67. Westbroek W., Gustafson A. M., Sidransky E., Exploring the link between glucocerebrosidase mutations and parkinsonism Trends in Molecular Medicine 2011 17 9 485 493
68. International Parkinson's Disease Genomics Consortium (IPDGC), A two-stage meta-analysis identifies several new loci for Parkinson's disease PLoS Genetics 2011 7 6, article e1002142
69. Gius D., Cui H., Bradbury C. M., Cook J., Smart D. K., Zhao S., Young L., Brandenburg S. A., Hu Y., Bisht K. S., Ho A. S., Mattson D., Sun L., Munson P. J., Chuang E. Y., Mitchell J. B., Feinberg A. P., Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach Cancer Cell 2004 6 4 361 371 (Pubitemid 39361437)
70. Obeid R., Schadt A., Dillmann U., Kostopoulos P., Fassbender K., Herrmann W., Methylation status and neurodegenerative markers in Parkinson disease Clinical Chemistry 2009 55 10 1852 1860
71. Herrmann W., Obeid R., Biomarkers of folate and vitamin B12 status in cerebrospinal fluid Clinical Chemistry and Laboratory Medicine 2007 45 12 1614 1620 (Pubitemid 350232960)
72. Jowaed A., Schmitt I., Kaut O., Wllner U., Methylation regulates alpha- synuclein expression and is decreased in Parkinson's disease patients' brains Journal of Neuroscience 2010 30 18 6355 6359
73. Matsumoto L., Takuma H., Tamaoka A., Kurisaki H., Date H., Tsuji S., Iwata A., CpG demethylation enhances alpha- synuclein expression and affects the pathogenesis of Parkinson's disease PLoS ONE 2010 5 11
74. Bnsch D., Lenz B., Kornhuber J., Bleich S., DNA hypermethylation of the alpha synuclein promoter in patients with alcoholism NeuroReport 2005 16 2 167 170 (Pubitemid 40250393)
75. Frieling H., Gozner A., Rmer K. D., Lenz B., Bnsch D., Wilhelm J., Hillemacher T., De Zwaan M., Kornhuber J., Bleich S., Global DNA hypomethylation and DNA hypermethylation of the alpha synuclein promoter in females with anorexia nervosa Molecular Psychiatry 2007 12 3 229 230 (Pubitemid 46328505)
76. Voutsinas G. E., Stavrou E. F., Karousos G., Dasoula A., Papachatzopoulou A., Syrrou M., Verkerk A. J. M. H., Van Der Spek P., Patrinos G. P., Stger R., Athanassiadou A., Allelic imbalance of expression and epigenetic regulation within the alpha- synuclein wild-type and p.Ala53Thr alleles in Parkinson disease Human Mutation 2010 31 6 685 691
77. Chiba-Falek O., Lopez G. J., Nussbaum R. L., Levels of alpha- synuclein mRNA in sporadic Parkinson disease patients Movement Disorders 2006 21 10 1703 1708 (Pubitemid 44742201)
78. Grndemann J., Schlaudraff F., Haeckel O., Liss B., Elevated -synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease Nucleic Acids Research 2008 36 7, article e38
79. Desplats P., Spencer B., Coffee E., Patel P., Michael S., Patrick C., Adame A., Rockenstein E., Masliah E., -synuclein sequesters Dnmt1 from the nucleus: a novel mechanism for epigenetic alterations in Lewy body diseases Journal of Biological Chemistry 2011 286 11 9031 9037
80. Agirre X., Romn-Gmez J., Vzquez I., Jiménez-Velasco A., Garate L., Montiel-Duarte C., Artieda P., Cordeu L., Lahortiga I., Calasanz M. J., Heiniger A., Torres A., Minna J. D., Prsper F., Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia International Journal of Cancer 2006 118 8 1945 1953
81. Goers J., Manning-Bog A. B., McCormack A. L., Millett I. S., Doniach S., Di Monte D. A., Uversky V. N., Fink A. L., Nuclear localization of -synuclein and its interaction with histones Biochemistry 2003 42 28 8465 8471 (Pubitemid 36875412)
82. Kontopoulos E., Parvin J. D., Feany M. B., -synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity Human Molecular Genetics 2006 15 20 3012 3023 (Pubitemid 44530705)
83. Jin H., Kanthasamy A., Ghosh A., Yang Y., Anantharam V., Kanthasamy A. G., -synuclein negatively regulates protein kinase C expression to suppress apoptosis in dopaminergic neurons by reducing p300 histone acetyltransferase activity Journal of Neuroscience 2011 31 6 2035 2051
84. Outeiro T. F., Kontopoulos E., Altmann S. M., Kufareva I., Strathearn K. E., Amore A. M., Volk C. B., Maxwell M. M., Rochet J. C., McLean P. J., Young A. B., Abagyan R., Feany M. B., Hyman B. T., Kazantsev A. G., Sirtuin 2 inhibitors rescue -synuclein -mediated toxicity in models of Parkinson's disease Science 2007 317 5837 516 519 (Pubitemid 47196116)
85. Monti B., Gatta V., Piretti F., Raffaelli S. S., Virgili M., Contestabile A., Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of -synuclein Neurotoxicity Research 2010 17 2 130 141
86. Kidd S. K., Schneider J. S., Protection of dopaminergic cells from MPP + -mediated toxicity by histone deacetylase inhibition Brain Research 2010 1354 C 172 178
87. Song C., Kanthasamy A., Jin H., Anantharam V., Kanthasamy A. G., Paraquat induces epigenetic changes by promoting histone acetylation in cell culture models of dopaminergic degeneration NeuroToxicology 2011 32 5 586 595
88. Song C., Kanthasamy A., Anantharam V., Sun F., Kanthasamy A. G., Environmental neurotoxic pesticide increases histone acetylation to promote apoptosis in dopaminergic neuronal cells: relevance to epigenetic mechanisms of neurodegeneration Molecular Pharmacology 2010 77 4 621 632
89. Kidd S. K., Schneider J. S., Protective effects of valproic acid on the nigrostriatal dopamine system in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease Neuroscience 2011 194 189 194
90. Chen S. H., Wu H. M., Ossola B., Schendzielorz N., Wilson B. C., Chu C. H., Chen S. L., Wang Q., Zhang D., Qian L., Li X., Hong J.-S., Lu R.-B., Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage British Journal of Pharmacology 2012 165 2 494 505
91. Vartiainen S., Pehkonen P., Lakso M., Nass R., Wong G., Identification of gene expression changes in transgenic C. elegans overexpressing human -synuclein Neurobiology of Disease 2006 22 3 477 486 (Pubitemid 43832121)
92. Gillardon F., Mack M., Rist W., Schnack C., Lenter M., Hildebrandt T., Hengerer B., MicroRNA and proteome expression profiling in early-symptomatic -synuclein (A30P)-transgenic mice Proteomics 2008 2 5 697 705 (Pubitemid 351772025)
93. Junn E., Lee K. W., Byeong S. J., Chan T. W., Im J. Y., Mouradian M. M., Repression of -synuclein expression and toxicity by microRNA-7 Proceedings of the National Academy of Sciences of the United States of America 2009 106 31 13052 13057
94. Doxakis E., Post-transcriptional regulation of -synuclein expression by mir-7 and mir-153 Journal of Biological Chemistry 2010 285 17 12726 12734
95. Asikainen S., Rudgalvyte M., Heikkinen L., Louhiranta K., Lakso M., Wong G., Nass R., Global microRNA expression profiling of caenorhabditis elegans Parkinson's disease models Journal of Molecular Neuroscience 2010 41 1 210 218
96. Gehrke S., Imai Y., Sokol N., Lu B., Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression Nature 2010 466 7306 637 641
97. Kim J., Inoue K., Ishii J., Vanti W. B., Voronov S. V., Murchison E., Hannon G., Abeliovich A., A microRNA feedback circuit in midbrain dopamine neurons Science 2007 317 5842 1220 1224
98. Miones-Moyano E., Porta S., Escarams G., Rabionet R., Iraola S., Kagerbauer B., Espinosa-Parrilla Y., Ferrer I., Estivill X., Mart E., MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function Human Molecular Genetics 2011 20 15 3067 3078
99. Margis R., Margis R., Rieder C. R.M., Identification of blood microRNAs associated to Parkinsons disease Journal of Biotechnology 2011 152 3 96 101
100. Maeda T., Guan J. Z., Oyama J. I., Higuchi Y., Makino N., Aging-associated alteration of subtelomeric methylation in Parkinson's disease Journals of Gerontology A 2009 64 9 949 955
101. Cai M., Tian J., Zhao G.-H., Luo W., Zhang B.-R., Study of methylation levels of parkin gene promoter in Parkinson's disease patients International Journal of Neuroscience 2011 121 9 497 502
102. Kagara I., Enokida H., Kawakami K., Matsuda R., Toki K., Nishimura H., Chiyomaru T., Tatarano S., Itesako T., Kawamoto K., Nishiyama K., Seki N., Nakagawa M., CpG hypermethylation of the UCHL1 gene promoter is associated with pathogenesis and poor prognosis in renal cell carcinoma Journal of Urology 2008 180 1 343 351
103. Yu J., Tao Q., Cheung K. F., Jin H., Poon F. F., Wang X., Li H., Cheng Y. Y., Rcken C., Ebert M. P. A., Chan A. T. C., Sung J. J. Y., Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors Hepatology 2008 48 2 508 518
104. Barrachina M., Ferrer I., DNA methylation of Alzheimer disease and tauopathy-related genes in postmortem brain Journal of Neuropathology and Experimental Neurology 2009 68 8 880 891
105. Pieper H. C., Evert B. O., Kaut O., Riederer P. F., Waha A., Wllner U., Different methylation of the TNF-alpha promoter in cortex and substantia nigra: implications for selective neuronal vulnerability Neurobiology of Disease 2008 32 3 521 527
106. Behrens M. I., Brggemann N., Chana P., Venegas P., Kgi M., Parrao T., Orellana P., Garrido C., Rojas C. V., Hauke J., Hahnen E., Gonzlez R., Seleme N., Fernndez V., Schmidt A., Binkofski F., Kmpf D., Kubisch C., Hagenah J., Klein C., Ramirez A., Clinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations Movement Disorders 2010 25 12 1929 1937
107. Berger S. L., The complex language of chromatin regulation during transcription Nature 2007 447 7143 407 412 (Pubitemid 46816746)
108. Chouliaras L., Rutten B. P. F., Kenis G., Peerbooms O., Visser P. J., Verhey F., van Os J., Steinbusch H. W. M., van den Hove D. L. A., Epigenetic regulation in the pathophysiology of Alzheimer's disease Progress in Neurobiology 2010 90 4 498 510
109. Du G., Liu X., Chen X., Song M., Yan Y., Jiao R., Wang C. C., Drosophila histone deacetylase 6 protects dopaminergic neurons against -synuclein toxicity by promoting inclusion formation Molecular Biology of the Cell 2010 21 13 2128 2137
110. Miki Y., Mori F., Tanji K., Kakita A., Takahashi H., Wakabayashi K., Accumulation of histone deacetylase 6, an aggresome-related protein, is specific to Lewy bodies and glial cytoplasmic inclusions Neuropathology 2011 31 6 561 568
111. Olzmann J. A., Li L., Chin L. S., Aggresome formation and neurodegenerative diseases: therapeutic implications Current Medicinal Chemistry 2008 15 1 47 60 (Pubitemid 351234627)
112. Su M., Shi J.-J., Yang Y.-P., Li J., Zhang Y.-L., Chen J., Hu L.-F., Liu C.-F., HDAC6 regulates aggresome-autophagy degradation pathway of -synuclein in response to MPP + -induced stress Journal of Neurochemistry 2011 117 1 112 120
113. Wang G., van der Walt J. M., Mayhew G., Li Y. J., Zchner S., Scott W. K., Martin E. R., Vance J. M., Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of -synuclein American Journal of Human Genetics 2008 82 2 283 289
114. de Mena L., Cardo L. F., Coto E., Miar A., Daz M., Corao A. I., Alonso B., Ribacoba R., Salvador C., Menéndez M., Mors G., Alvarez V., FGF20 rs 12720208 SNP and microRNA-433 variation: no association with Parkinson's disease in Spanish patients Neuroscience Letters 2010 479 1 22 25
115. D'Mello S. R., Histone deacetylases as targets for the treatment of human neurodegenerative diseases Drug News and Perspectives 2009 22 9 513 524
116. Harraz M. M., Dawson T. M., Dawson V. L., MicroRNAs in Parkinson's disease Journal of Chemical Neuroanatomy 2011 42 2 127 130